Related Experiment Videos
[Limb girdle muscular dystrophies]
1Neurologische Abteilung, KA Rudolfstiftung, Wien, Osterreich. duarte@aonmail.at
Der Nervenarzt
|August 19, 2004
Summary
Limb girdle muscular dystrophies (LGMDs) are genetic muscle-wasting diseases affecting the hips and shoulders. Diagnosis relies on DNA analysis, as no causal therapy currently exists for these progressive myopathies.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Context:
- Limb girdle muscular dystrophies (LGMDs) represent a group of genetically diverse primary myopathies.
- Characterized by progressive weakness and wasting of the hip and shoulder girdle muscles.
- Rarely, distal spread to bulbar or respiratory muscles may occur.
Purpose:
- To outline the genetic heterogeneity and clinical spectrum of LGMDs.
- To detail the known genetic causes and inheritance patterns of LGMDs.
- To highlight diagnostic approaches and the current lack of causal therapies.
Summary:
- LGMDs encompass autosomal dominant (10-25%) and autosomal recessive (75-90%) forms, with varying prevalence (0.8/100,000).
- Mutations in specific genes (e.g., myotilin, lamin A/C, calpain-3, dysferlin) cause these conditions.
- Cardiac involvement is noted in several LGMD subtypes; onset and progression vary widely.
Impact:
- Understanding the genetic basis of LGMDs is crucial for accurate diagnosis and genetic counseling.
- The diagnostic process integrates DNA analysis with clinical and electrophysiological findings.
- Current research focuses on developing causal therapies for these debilitating muscle disorders.